Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,267 | 540 | 97.8% |
| Education | $164.72 | 39 | 2.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| AstraZeneca Pharmaceuticals LP | $885.49 | 63 | $0 (2024) |
| Novo Nordisk Inc | $764.30 | 81 | $0 (2024) |
| Lilly USA, LLC | $699.67 | 76 | $0 (2024) |
| GlaxoSmithKline, LLC. | $658.51 | 59 | $0 (2024) |
| Amgen Inc. | $627.80 | 43 | $0 (2024) |
| Takeda Pharmaceuticals U.S.A., Inc. | $471.52 | 30 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $404.61 | 25 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $386.81 | 22 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $278.31 | 19 | $0 (2023) |
| PFIZER INC. | $256.95 | 22 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $702.20 | 36 | Novartis Pharmaceuticals Corporation ($132.11) |
| 2023 | $864.62 | 54 | GlaxoSmithKline, LLC. ($147.61) |
| 2022 | $721.86 | 44 | Takeda Pharmaceuticals U.S.A., Inc. ($131.17) |
| 2021 | $557.66 | 37 | Novo Nordisk Inc ($116.59) |
| 2020 | $341.97 | 23 | AstraZeneca Pharmaceuticals LP ($72.23) |
| 2019 | $1,080 | 73 | AstraZeneca Pharmaceuticals LP ($223.60) |
| 2018 | $1,442 | 132 | AstraZeneca Pharmaceuticals LP ($356.17) |
| 2017 | $1,720 | 180 | Lilly USA, LLC ($179.36) |
All Payment Transactions
579 individual payment records from CMS Open Payments — Page 1 of 24
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $13.22 | General |
| Category: Respiratory | ||||||
| 12/04/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $13.44 | General |
| Category: Diabetes | ||||||
| 10/28/2024 | Grifols USA, LLC | Prolastin-C Liquid (Biological) | Food and Beverage | In-kind items and services | $21.10 | General |
| Category: Pulmonology | ||||||
| 10/25/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.49 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/23/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug) | Food and Beverage | In-kind items and services | $19.65 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: Diabetes | ||||||
| 07/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | OFEV (Drug) | Food and Beverage | In-kind items and services | $23.92 | General |
| Category: RESPIRATORY | ||||||
| 07/08/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.84 | General |
| Category: Diabetes | ||||||
| 07/01/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.21 | General |
| Category: Biological | ||||||
| 06/27/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $16.62 | General |
| Category: Diabetes | ||||||
| 06/18/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug) | Food and Beverage | In-kind items and services | $14.48 | General |
| Category: Gastroenterology | ||||||
| 06/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $18.59 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/03/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $17.77 | General |
| Category: Obesity | ||||||
| 05/31/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $25.76 | General |
| Category: NEUROSCIENCE | ||||||
| 05/24/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $28.85 | General |
| Category: Diabetes Care | ||||||
| 05/08/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $23.62 | General |
| Category: RESPIRATORY | ||||||
| 05/02/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.08 | General |
| Category: Diabetes | ||||||
| 04/30/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $18.82 | General |
| Category: Cardio-renal | ||||||
| 04/17/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $19.59 | General |
| Category: DIABETES | ||||||
| 04/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Diabetes | ||||||
| 04/11/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $17.90 | General |
| Category: PSYCHIATRY | ||||||
| 03/28/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug) | Food and Beverage | In-kind items and services | $24.82 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/21/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological), AREXVY | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: VACCINES | ||||||
| 03/04/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.57 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 1,749 | 3,210 | $719,441 | $204,573 |
| 2022 | 20 | 1,367 | 2,727 | $773,957 | $218,706 |
| 2021 | 20 | 1,431 | 3,204 | $877,191 | $268,187 |
| 2020 | 22 | 1,723 | 3,353 | $754,411 | $239,355 |
All Medicare Procedures & Services
82 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 275 | 861 | $252,335 | $69,506 | 27.5% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 220 | 777 | $173,102 | $47,337 | 27.3% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 193 | 193 | $48,128 | $24,108 | 50.1% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 125 | 243 | $75,595 | $22,504 | 29.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 81 | 88 | $29,182 | $7,690 | 26.4% |
| 99496 | Transitional care management services for problem of high complexity | Office | 2023 | 26 | 28 | $20,838 | $5,960 | 28.6% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 37 | 39 | $18,200 | $3,672 | 20.2% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 25 | 26 | $15,645 | $3,541 | 22.6% |
| G0438 | Annual wellness visit; includes a personalized prevention plan of service (pps), initial visit | Office | 2023 | 22 | 22 | $8,158 | $3,527 | 43.2% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 49 | 50 | $10,798 | $3,446 | 31.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 463 | 544 | $16,791 | $3,339 | 19.9% |
| 99495 | Transitional care management services for problem of at least moderate complexity | Office | 2023 | 15 | 17 | $9,711 | $2,670 | 27.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 26 | 26 | $10,058 | $2,362 | 23.5% |
| 20610 | Aspiration and/or injection of fluid from large joint | Office | 2023 | 22 | 43 | $17,137 | $1,985 | 11.6% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 56 | $4,097 | $1,646 | 40.2% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 52 | 66 | $5,242 | $648.03 | 12.4% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 21 | 44 | $2,641 | $399.97 | 15.1% |
| J1040 | Injection, methylprednisolone acetate, 80 mg | Office | 2023 | 20 | 23 | $923.20 | $191.85 | 20.8% |
| J3420 | Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg | Office | 2023 | 12 | 28 | $682.60 | $28.13 | 4.1% |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | Office | 2023 | 11 | 36 | $175.50 | $13.05 | 7.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 283 | 789 | $221,994 | $62,622 | 28.2% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 146 | 663 | $196,944 | $52,889 | 26.9% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2022 | 184 | 184 | $44,265 | $23,109 | 52.2% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 123 | 396 | $85,100 | $21,881 | 25.7% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 86 | 90 | $52,490 | $13,663 | 26.0% |
About Dr. Mohamed Ali, M.D
Dr. Mohamed Ali, M.D is a Internal Medicine healthcare provider based in Bay City, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/31/2006. The National Provider Identifier (NPI) number assigned to this provider is 1881705580.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Mohamed Ali, M.D has received a total of $7,432 in payments from pharmaceutical and medical device companies, with $702.20 received in 2024. These payments were reported across 579 transactions from 46 companies. The most common payment nature is "Food and Beverage" ($7,267).
As a Medicare-enrolled provider, Ali has provided services to 6,270 Medicare beneficiaries, totaling 12,494 services with total Medicare billing of $930,822. Data is available for 4 years (2020–2023), covering 82 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Bay City, MI
- Active Since 08/31/2006
- Last Updated 10/04/2007
- Taxonomy Code 207R00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1881705580
Products in Payments
- SYMBICORT (Drug) $525.01
- TRINTELLIX (Drug) $364.32
- Prolia (Biological) $260.32
- TRELEGY ELLIPTA (Drug) $246.99
- ENTRESTO (Drug) $238.95
- HUMALOG (Drug) $204.66
- FARXIGA (Drug) $201.61
- MOUNJARO (Drug) $191.46
- Aimovig (Biological) $190.01
- JARDIANCE (Drug) $183.02
- XARELTO (Drug) $177.29
- Saxenda (Drug) $165.18
- ANORO (Drug) $159.99
- TRULICITY (Drug) $150.13
- LEQVIO (Drug) $147.86
- QULIPTA (Drug) $145.62
- Edwards SAPIEN 3 Transcatheter Heart Valve (Device) $135.29
- Ozempic (Drug) $135.14
- Victoza (Drug) $124.41
- CHANTIX (Drug) $119.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Bay City
Jeffrey Potts, Md, MD
Internal Medicine — Payments: $120,027
Dr. Gassan Alaouie, Do, DO
Internal Medicine — Payments: $16,907
Barry Liberoni, Md, MD
Internal Medicine — Payments: $8,962
Dr. Praveen Kamaraju, M.d, M.D
Internal Medicine — Payments: $7,427
Dr. Naeem Ahmed, M.d, M.D
Internal Medicine — Payments: $6,432
Dr. Lakshmi Arekapudi, M.d, M.D
Internal Medicine — Payments: $6,196